James Lind Alliance Logo

The James Lind Alliance

The James Lind Alliance (JLA) brings patients, carers and clinicians together to identify and prioritise uncertainties, or ‘unanswered questions’, about the effects of treatments. The process is known as a Priority Setting Partnership, or PSP. The information gathered helps to ensure that those who fund and carry out health research are aware of the questions that really matter.  

 

The JLA is a not-for-profit initiative which was established in 2004.

The infrastructure for the JLA is funded by the National Institute for Health Research (NIHR).

 

The NIHR does not normally fund individual JLA PSPs but it has initiated funding the following in priority areas:

 

Alcohol-related liver disease PSP

Alcohol-related liver disease

The Alcohol-Related Liver Disease (ARLD) Priority Setting Partnership (PSP) brought together people with alcohol-related liver disease, their families, carers and the healthcare professionals who treat them to help set priorities for research.

Mesothelioma PSP

Mesothelioma

The Mesothelioma Priority Setting Partnership (PSP) brought together people with mesothelioma, their families, carers and the healthcare professionals who treat them to help set priorities for mesothelioma research.